论文部分内容阅读
1例45岁男性患者,因上呼吸道感染,给予头孢噻肟钠4g加入0.9%氯化钠注射液250mL静脉滴注,双黄连注射液40mL加入5%葡萄糖注射液250mL静脉滴注。第2天继续给予头孢噻肟钠和双黄连注射液静脉滴注,未出现不良反应,当加用利巴韦林静脉滴注至50mL时,患者出现面色苍白、胸闷、气促,BP40/10mmHg,立即停止输液,给予吸氧、肾上腺素、地塞米松、多巴胺、葡萄糖酸钙治疗,症状好转。第3天未使用利巴韦林,患者未再发生不良反应。
A 45-year-old man with upper respiratory tract infection was given cefotaxime sodium 4g by adding 0.9% sodium chloride injection 250mL intravenous infusion Shuanghuanglian injection 40mL 5% glucose injection 250mL intravenous infusion. Continue to give cefotaxime sodium and Shuanghuanglian intravenous drip on the second day, no adverse reactions, when plus plus intravenous ribavirin to 50mL, the patient appeared pale, chest tightness, shortness of breath, BP40 / 10mmHg , Immediately stop infusion, given oxygen, epinephrine, dexamethasone, dopamine, calcium gluconate treatment, the symptoms improved. Ribavirin was not used on the third day and no adverse reactions occurred in the patient.